Cytokine profiling in Iranian patients with COVID-19; association with clinical severity
- PMID: 33787514
- DOI: 10.22034/iji.2021.87630.1810
Cytokine profiling in Iranian patients with COVID-19; association with clinical severity
Abstract
Background: SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), is recognized for the first time in Wuhan, China. The cytokine storm is a known factor causing major clinical symptoms leading to death in COVID-19 patients.
Objective: To investigate and compare the serum levels of different cytokines in COVID-19 patients with different clinical severity.
Methods: Concentrations of serum cytokines, including IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α, IFN-γ, and GM-CSF, were measured in 61 COVID-19 patients and 31 normal controls with ELISA. We investigated the correlation between the levels of these cytokines and clinical severity, CRP level, neutrophil and lymphocyte count in patients with COVID-19.
Results: Our data indicated that the levels of IL-1β, IL-2, IL-4, IL-6, IL-8, TNF-α, IFN-γ, and GM-CSF, but not IL-10 were significantly increased in COVID-19 patients compared to normal controls. Statistical analysis showed that the level of IL-1β, IL-2, IL-4, IL-6, IL-8, TNF-α, IFN-γ, and GM-CSF were higher in severe COVID-19 than those of mild cases. The concentrations of all mentioned cytokines were negatively associated with the absolute count of lymphocytes, and positively correlated with the CRP level and the absolute count of neutrophils.
Conclusion: The current study suggests that high levels of various cytokines correlate with the disease severity and immunopathogenesis of COVID-19.
Similar articles
-
Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.Cytokine. 2022 Mar;151:155804. doi: 10.1016/j.cyto.2022.155804. Epub 2022 Jan 18. Cytokine. 2022. PMID: 35063722 Free PMC article.
-
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.Expert Rev Mol Diagn. 2020 Nov;20(11):1087-1097. doi: 10.1080/14737159.2020.1830760. Epub 2020 Oct 12. Expert Rev Mol Diagn. 2020. PMID: 32990479
-
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.Emerg Microbes Infect. 2020 Dec;9(1):1123-1130. doi: 10.1080/22221751.2020.1770129. Emerg Microbes Infect. 2020. PMID: 32475230 Free PMC article.
-
SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.Front Immunol. 2021 Mar 1;12:629193. doi: 10.3389/fimmu.2021.629193. eCollection 2021. Front Immunol. 2021. PMID: 33732251 Free PMC article.
-
Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.J Clin Immunol. 2021 Jan;41(1):11-22. doi: 10.1007/s10875-020-00899-z. Epub 2020 Oct 31. J Clin Immunol. 2021. PMID: 33128665 Free PMC article.
Cited by
-
IL1β, IL-6, and TNF-α cytokines cooperate to modulate a complicated medical condition among COVID-19 patients: case-control study.Ann Med Surg (Lond). 2023 Apr 26;85(6):2291-2297. doi: 10.1097/MS9.0000000000000679. eCollection 2023 Jun. Ann Med Surg (Lond). 2023. PMID: 37363608 Free PMC article.
-
Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management.Int J Mol Sci. 2023 Mar 24;24(7):6142. doi: 10.3390/ijms24076142. Int J Mol Sci. 2023. PMID: 37047115 Free PMC article. Review.
-
Polymorphisms Influence the Expression of the Fas and FasL Genes in COVID-19.Int J Mol Sci. 2025 Jan 14;26(2):666. doi: 10.3390/ijms26020666. Int J Mol Sci. 2025. PMID: 39859379 Free PMC article.
-
Comparison of laboratory parameters in mild vs. severe cases and died vs. survived patients with COVID-19: systematic review and meta-analysis.J Thorac Dis. 2022 May;14(5):1478-1487. doi: 10.21037/jtd-22-345. J Thorac Dis. 2022. PMID: 35693606 Free PMC article.
-
MicroRNAs and cytokines as potential predictive biomarkers for COVID-19 disease progression.Sci Rep. 2023 Mar 2;13(1):3531. doi: 10.1038/s41598-023-30474-6. Sci Rep. 2023. PMID: 36864077 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous